← Back to Search

Osteopathic Manipulative Therapy for Respiratory Diseases

N/A

Waitlist Available

Led By Margaret Moore, DO

Research Sponsored by Geisinger Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients age of 65-100

Be older than 65 years old

Must not have

Patients with active or previously diagnosed liver disease

Patients that have a healing fracture, including the spine, pelvis, shoulder, ribs, vertebrae, or extremities

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion of up to one year.

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to investigate whether Osteopathic Manipulative Therapy (OMT) can help patients with respiratory illnesses and their symptoms. The study will see if adding OMT to standard care can reduce symptoms

Who is the study for?

This trial is for patients recently diagnosed with respiratory illnesses like bronchitis, sinus infections, and pneumonia. It's open to those who are receiving standard care for these conditions but have not yet tried Osteopathic Manipulative Therapy (OMT).

What is being tested?

The study tests if adding OMT to usual care improves recovery in respiratory illness patients. The goal is to see if symptoms resolve faster and the overall sickness duration decreases compared to standard treatment alone.

What are the potential side effects?

OMT is a manual therapy so potential side effects may include discomfort during or after treatment, minor bruising, headache, or fatigue. However, it's generally considered safe with minimal risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 65 and 100 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have or had liver disease.

Select...

I am currently healing from a bone fracture.

Select...

I am currently undergoing cancer treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion of up to one year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion of up to one year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion of up to one year. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

To address the magnitude in which lymphatic pump OMT improves respiratory illness symptom severity and overall sickness duration when combined with standard care treatment.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TreatmentExperimental Treatment1 Intervention

Patients will receive lymphatic pump OMT therapy in addition to other standard care (similar to the control patients, this would be a medication, follow-up instructions, etc.)

Group II: ControlActive Control1 Intervention

Patients in the control group will receive normal standard care, including any prescriptions, follow-up instructions, etc., as given by the provider to help treat their condition.

0 / 4Eligibility criteria met